GRIA2
GRIA2 (glutamate ionotropic receptor AMPA type subunit 2, also known as GluA2, GluR-B, GluR-2 and GLURB) is a subunit of the AMPA-type ionotropic glutamate receptor. It forms part of a ligand-gated cation channel that mediates fast excitatory synaptic transmission in the central nervous system. Browse Assay Genie's current range of GRIA2 research reagents below, or read on for the biology behind the target.
GRIA2 is an ionotropic glutamate receptor subunit that functions as a ligand-gated cation channel. It is gated by L-glutamate and by glutamatergic agonists such as AMPA, quisqualic acid and kainic acid. L-glutamate is an excitatory neurotransmitter at many synapses in the central nervous system, and binding induces a conformational change that opens the channel. This converts a chemical signal into an electrical impulse as monovalent and divalent cations, such as sodium and calcium, enter the cell. The receptor then desensitises rapidly and enters a transient inactive state with agonist still bound. In the presence of CACNG4, CACNG7 or CACNG8, it shows resensitisation, seen as a delayed accumulation of current during continued glutamate application.
Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain. AMPA-sensitive channels are assembled from four related subunits, GRIA1 to GRIA4, and the GRIA2 gene encodes one of them. The protein belongs to the glutamate-gated ion channel family and is found at the cell membrane, including the postsynaptic membrane and postsynaptic density. Through complex formation with NSG1, GRIP1 and STX12, it helps control the intracellular fate of AMPA receptors, directing endosomal sorting of the GRIA2 subunit towards recycling and membrane targeting.
The GRIA2 transcript is subject to RNA editing (CAG to CGG; Q to R) within the second transmembrane domain, which is thought to render the channel impermeable to Ca(2+). Human and animal studies suggest that pre-mRNA editing is essential for brain function, and defective editing at the Q/R site may be relevant to the aetiology of amyotrophic lateral sclerosis. Alternative splicing yields transcript variants encoding different isoforms, including flip and flop forms that differ in their signal transduction properties. The previous HGNC name was glutamate receptor, ionotropic, AMPA 2.
GRIA2 contributes to fast excitatory synaptic transmission, converting glutamate binding into cation flux at central nervous system synapses.
Desensitisation and CACNG-dependent resensitisation make GRIA2 a useful subject for studying how AMPA receptor channels are gated and modulated.
Q/R site editing of GRIA2 is thought to control calcium permeability and is essential for brain function.
Defective GRIA2 RNA editing at the Q/R site may be relevant to the aetiology of amyotrophic lateral sclerosis.
GRIA2 is a subunit of AMPA-type glutamate receptors, which are ligand-gated cation channels. When L-glutamate binds, the channel opens and sodium and calcium ions can enter, converting a chemical signal into an electrical impulse at excitatory synapses. The receptor then desensitises rapidly.
GRIA2 is also called GluA2, GLURB, GluR-K2, GluR-B, GluR-2 and GLUR2, and was previously named glutamate receptor, ionotropic, AMPA 2. Alternative splicing produces several isoforms, including flip and flop variants that differ in their signal transduction properties.
Defective GRIA2 RNA editing at the Q/R site may be relevant to amyotrophic lateral sclerosis. Orthologs exist in mouse and rat, both named Gria2; check the datasheet of any product for its validated reactivity.
Other AMPA receptor subunits that assemble with GRIA2 into glutamate-gated cation channels.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P42262; product specifications from Assay Genie datasheets.